Development
Cognex Corporation
CGNX
$41.08
$0.1850.45%
NASDAQ
| 12/31/2023 | 10/01/2023 | 07/02/2023 | 04/02/2023 | 12/31/2022 | |
|---|---|---|---|---|---|
| Revenue | 196.67M | 197.24M | 242.51M | 201.12M | 239.43M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 196.67M | 197.24M | 242.51M | 201.12M | 239.43M |
| Cost of Revenue | 61.63M | 54.47M | 62.83M | 57.38M | 69.87M |
| Gross Profit | 135.04M | 142.77M | 179.68M | 143.74M | 169.56M |
| SG&A Expenses | 90.37M | 82.31M | 83.42M | 83.04M | 75.95M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 186.69M | 169.35M | 179.84M | 178.96M | 182.95M |
| Operating Income | 9.98M | 27.89M | 62.68M | 22.16M | 56.48M |
| Income Before Tax | 14.35M | 27.00M | 67.78M | 26.22M | 59.23M |
| Income Tax Expenses | 3.13M | 8.09M | 10.30M | 600.00K | 3.92M |
| Earnings from Continuing Operations | 11.23M | 18.92M | 57.47M | 25.62M | 55.31M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 11.23M | 18.92M | 57.47M | 25.62M | 55.31M |
| EBIT | 9.98M | 27.89M | 62.68M | 22.16M | 56.48M |
| EBITDA | 16.87M | 33.01M | 67.61M | 27.09M | 61.46M |
| EPS Basic | 0.07 | 0.11 | 0.33 | 0.15 | 0.32 |
| Normalized Basic EPS | 0.04 | 0.09 | 0.24 | 0.09 | 0.22 |
| EPS Diluted | 0.06 | 0.11 | 0.33 | 0.15 | 0.32 |
| Normalized Diluted EPS | 0.04 | 0.09 | 0.24 | 0.09 | 0.22 |
| Average Basic Shares Outstanding | 171.77M | 172.17M | 172.43M | 172.62M | 172.69M |
| Average Diluted Shares Outstanding | 172.57M | 173.35M | 173.62M | 173.90M | 173.90M |
| Dividend Per Share | 0.08 | 0.07 | 0.07 | 0.07 | 0.07 |
| Payout Ratio | 114.61% | 63.70% | 21.00% | 47.20% | 21.85% |